phenacetin
acetamide, N-(4-ethoxyphenyl)- (9CI)
Identification
| Name | phenacetin |
| CAS Number | 62-44-2 |
| EINECS | 200-533-0 |
| FDA UNII | ER0CTH01H9 |
| Molecular Formula | C10 H13 N O2 |
| Molecular Weight | 179.21901000 |
| MDL Number | MFCD00009094 |
| Nikkaji Number | J2.348E |
| Beilstein | 1869238 |
| XlogP3 | 1.60 (est) |
Regulatory
Physical Properties
| Appearance | white fine crystalline solid (est) |
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Melting Point | 137.50 °C. @ 760.00 mm Hg |
| Boiling Point | 355.10 °C. @ 760.00 mm Hg (est) |
| Flash Point | 335.00 °F. TCC ( 168.50 °C. ) (est) |
| logP (o/w) | 1.580 |
| Soluble in | water, 766 mg/L @ 25 °C (exp) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | stabilising agents |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | intravenous-dog LDLo 260 mg/kg |
| Dermal Toxicity | subcutaneous-mouse LD50 1625 mg/kg |
| Inhalation Toxicity | inhalation-mouse LC50 33900 mg/m3 |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | stabilizing agents |
| Recommendation for phenacetin usage levels up to | not for fragrance use. |
| Recommendation for phenacetin flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Glentham Life Sciences Ltd
The Chemical, Biochemical & Research Essentials Supplier
Glentham Life Sciences is a supplier of fine chemicals and raw materials with warehousing, laboratories and packaging facilities in the UK.
Potential Uses
Natural Occurrence
Synonyms
acetamide, N-(4-ethoxyphenol)-
acetamide, N-(4-ethoxyphenyl)-
acetamide, N-(4-ethoxyphenyl)- (9CI)
1-
acetamido-4-ethoxybenzene
acetanilide, 4'-ethoxy-
acetanilide, p-ethoxy-
aceto-4-phenetidine
aceto-p-phenetidin
aceto-para-phenalide
aceto-para-phenetidide
4-
acetophenetidide
p-
acetophenetidide
para-
acetophenetidide
acetophenetidin
acetophenetidine
para-
acetophenetidine
acetophenetin
acetphenetidin
para-
acetphenetidin
N-
acetyl-4-ethoxyaniline
N-
acetyl-p-ethoxyaniline
1-
acetyl-p-phenetidin
N-
acetyl-p-phenetidine
N-
acetyl-para-phenetidine
4-(
acetylamino)phenetole
achrocidin
clistanol
codempiral
commotional
contradouleur
coryban-D
daprisal
dasikon
dolostop
dolviran
empiral
emprazil
4-
ethoxyacetanilide
4'-
ethoxyacetanilide
p-
ethoxyacetanilide
para-
ethoxyacetanilide
N-(4-
ethoxyphenol)acetamide
N-(4-
ethoxyphenyl)-acetamide
N-(4-
ethoxyphenyl)acetamide
N-[4-(
ethyloxy)phenyl]acetamide
fenidina
fortacyl
helvagit
melaforte
p-
phenacetin
para-
phenacetin
phenacetine
phenacetinum
phenacitin
phenacon
p-
phenetidine, N-acetyl-
phenodyne
quadronal
stellacyl
terracydin
veganine
wigraine
PubMed:
Highly sensitive LC-MS/MS method for determination of galantamine in rat plasma: application to pharmacokinetic studies in rats.
PubMed:
Simultaneous determination of Guanfu base G and its active metabolites by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
PubMed:
A simple assay for the simultaneous determination of human plasma albendazole and albendazole sulfoxide levels by high performance liquid chromatography in tandem mass spectrometry with solid-phase extraction.
PubMed:
Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.
PubMed:
Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes.
PubMed:
Increased exposure of vitamin A by Chrysanthemum morifolium Ramat extract in rat was not via induction of CYP1A1, CYP1A2, and CYP2B1.
PubMed:
Effects of Ougan juice on P450 activities using a cocktail method.
PubMed:
Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
PubMed:
Technical modification of the Balb/c 3T3 cell transformation assay: the use of serum-reduced medium to optimise the practicability of the protocol.
PubMed:
The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
PubMed:
Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
PubMed:
[Novel potential uses of thalidomide in the management of pain? A review of the literature].
PubMed:
Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.
PubMed:
Neonatal mouse model: review of methods and results.
PubMed:
Epidemiology and etiology of premalignant and malignant urothelial changes.
PubMed:
Dose selection for carcinogenicity studies of pharmaceuticals: systemic exposure to phenacetin at carcinogenic dosage in the rat.
PubMed:
Optimum conditions for the 13C-phenylalanine breath test.
PubMed:
Liquid chromatographic determination of thalidomide in tablets, capsules, and raw materials.
PubMed:
A rapid, specific, and sensitive method for the determination of acetylation phenotype using dapsone.
PubMed:
Influence of diet and nutritional status on drug metabolism.
PubMed:
Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes.
PubMed:
Nitrosamine formation via non-prescription drugs?
PubMed:
Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes.
PubMed:
Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.
PubMed:
The effect of food dye and other environmental substances on the host defense reaction in mice in relation to virus infection.
PubMed:
Food-borne amines and amides as potential precursors of endogenous carcinogens.
PubMed:
Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
PubMed:
Food interactions affecting the absorption of analgesic and anti-inflammatory agents.
PubMed:
Proposal to remove phenacetin from analgesics.
PubMed:
Tobacco use, occupation, coffee, various nutrients, and bladder cancer.
PubMed:
Research review. Interactions between environmental chemicals and drug biotransformation in man.
PubMed:
Influence of food on the bioavailability of drugs.
PubMed:
Discriminative stimulus properties of analgesic drugs: narcotic versus non-narcotic analgesics.
PubMed:
Urinary enzymes and kidney damage by aspirin and phenacetin.
PubMed:
Inhibitory effects of lipophilic acids and related compounds on bacteria and mammalian cells.
PubMed:
Caffeine in America's food and drug habits.
PubMed:
Unravelling analgesic nephropathy.
PubMed:
General and renal toxicity of phenacetin, paracetamol and some anti-mitotic agents in the rat.
PubMed:
Phenacetin as a carcinogen: an unsatisfactory picture.
PubMed:
Drug safety: experimental programs.